Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea
NCT06268054 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78
Last updated 2024-02-22
Summary
The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Conditions
- Primary Dysmenorrhea
Interventions
- DRUG
-
DEH113
Tablets
- DRUG
-
Placebo Comparator
Tablets
Sponsors & Collaborators
-
EMS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 16 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-28
- Primary Completion
- 2027-02-28
- Completion
- 2027-09-30
More Related Trials
-
A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain
NCT05101317 ·Status: COMPLETED ·Phase: PHASE2
-
Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea
NCT03269591 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
NCT05560646 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
NCT06995287 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain
NCT07318688 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Postoperative Desogestrel for Endometriosis Related Pain
NCT01559480 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
NCT03070951 ·Status: COMPLETED ·Phase: PHASE3
-
Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study
NCT02542410 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
NCT00117481 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Pain Risk Associated With Menstrual Period Pain
NCT02214550 ·Status: COMPLETED ·Phase: PHASE4
-
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
NCT04607382 ·Status: COMPLETED
-
Efficacy of Manual Therapy to Improve Quality of Life and Decrease Pain in Subjects With Endometriosis
NCT03118154 ·Status: TERMINATED
-
Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea
NCT01250587 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea
NCT06317064 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT06963177 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT05648669 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
NCT03840993 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
NCT01116440 ·Status: TERMINATED ·Phase: PHASE2
-
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
NCT01533532 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)
NCT03654326 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids
NCT05442827 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ulipristal for Endometriosis-related Pelvic Pain
NCT02213081 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis
NCT02778399 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain
NCT01760954 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
NCT05445167 ·Status: COMPLETED ·Phase: PHASE3